160 related articles for article (PubMed ID: 12674844)
1. "Warning card" as a prevention of prolonged apnea in children.
Lajtman Z; Surina B; Bartolek D; Car D; Gasparović S; Kirincić N; Rudez J
Coll Antropol; 2002 Dec; 26 Suppl():129-37. PubMed ID: 12674844
[TBL] [Abstract][Full Text] [Related]
2. Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.
Vaisi-Raygani A; Rahimi Z; Kharazi H; Tavilani H; Aminiani M; Kiani A; Vaisi-Raygani A; Pourmotabbed T
Clin Biochem; 2007 Jun; 40(9-10):629-33. PubMed ID: 17350607
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterase unit establishment and issuing of >>Warning Cards<< for carriers of suxamethonium sensitive serum butyrylcholinesterase variants.
Surina B; Nosso D; Siftar Z; Flegar-Mestrić Z; Simeon-Rudolf V
Coll Antropol; 2004; 28 Suppl 2():297-304. PubMed ID: 15571104
[TBL] [Abstract][Full Text] [Related]
4. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
5. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India.
Manoharan I; Wieseler S; Layer PG; Lockridge O; Boopathy R
Pharmacogenet Genomics; 2006 Jul; 16(7):461-8. PubMed ID: 16788378
[TBL] [Abstract][Full Text] [Related]
7. Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk.
Lockridge O; Masson P
Neurotoxicology; 2000; 21(1-2):113-26. PubMed ID: 10794391
[TBL] [Abstract][Full Text] [Related]
8. Ethnic differences in the frequency of distribution of serum cholinesterase activity in the Iranian population.
Vahdati-Mashhadian N; Hassanzadeh MK; Hosseini J; Saffareshargh AA
Can J Physiol Pharmacol; 2004 May; 82(5):326-30. PubMed ID: 15213732
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase: phenotyping and genotyping.
Goodall R;
Ann Clin Biochem; 2004 Mar; 41(Pt 2):98-110. PubMed ID: 15025799
[TBL] [Abstract][Full Text] [Related]
10. Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
Mintjens N; Brummans R; Soetens F; Claes KBM; Vanlinthout LE
Acta Anaesthesiol Scand; 2021 Feb; 65(2):182-187. PubMed ID: 33010031
[TBL] [Abstract][Full Text] [Related]
11. Possible influence of BCHE locus of butyrylcholinesterase on stature and body mass index.
Souza RL; Fadel-Picheth C; Allebrandt KV; Furtado L; Chautard-Freire-Maia EA
Am J Phys Anthropol; 2005 Mar; 126(3):329-34. PubMed ID: 15386241
[TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
Mollerup HM; Gätke MR
Acta Anaesthesiol Scand; 2011 Jan; 55(1):82-6. PubMed ID: 21029050
[TBL] [Abstract][Full Text] [Related]
13. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants.
Kovarik Z; Simeon-Rudolf V
Arh Hig Rada Toksikol; 2003 Dec; 54(4):239-44. PubMed ID: 14994645
[TBL] [Abstract][Full Text] [Related]
14. [Apnea after general anesthesia for revision of uterus in parturient with K-variant of the butyrylcholinesterase enzyme (BChE)].
Miller-Roll T; Pilcha I; Weksler N; Negomireanu S; Bahar M
Harefuah; 2012 Jul; 151(7):402-4, 436. PubMed ID: 23002690
[TBL] [Abstract][Full Text] [Related]
15. The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency.
Li B; Duysen EG; Carlson M; Lockridge O
J Pharmacol Exp Ther; 2008 Mar; 324(3):1146-54. PubMed ID: 18056867
[TBL] [Abstract][Full Text] [Related]
16. [Phenotype of plasma cholinesterase in prolonged apnea and sensitivity to succinylcholine].
Burnat P; Jacquot C; Alcalay A; Zaoui P
Cah Anesthesiol; 1987 Dec; 35(8):601-5. PubMed ID: 3442754
[TBL] [Abstract][Full Text] [Related]
17. Human butyrylcholinesterase L330I mutation belongs to a fluoride-resistant gene, by expression in human fetal kidney cells.
Sudo K; Maekawa M; Akizuki S; Magara T; Ogasawara H; Tanaka T
Biochem Biophys Res Commun; 1997 Nov; 240(2):372-5. PubMed ID: 9388484
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
Delacour H; Lushchekina S; Mabboux I; Bousquet A; Ceppa F; Schopfer LM; Lockridge O; Masson P
PLoS One; 2014; 9(7):e101552. PubMed ID: 25054547
[TBL] [Abstract][Full Text] [Related]
19. Five new naturally occurring mutations of the BCHE gene and frequencies of 12 butyrylcholinesterase alleles in a Brazilian population.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Nachon F; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2008 Mar; 18(3):213-8. PubMed ID: 18300943
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutations in the plasma cholinesterase gene of patients with a history of prolonged neuromuscular block during anesthesia.
Barta C; Sasvari-Szekely M; Devai A; Kovacs E; Staub M; Enyedi P
Mol Genet Metab; 2001 Dec; 74(4):484-8. PubMed ID: 11749053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
